| -
Novartis i miljardaffär
Det schweiziska läkemedelsbolaget Novartis säljer USA-rättigheterna till läkemedlet Enablex mot överaktiv blåsa för inledningsvis 400 miljoner dollar, motsvarande närmare 2,8 miljarder kronor. Köpare är Irlandsbaserade Warner Chilcott.
More...
|
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
Disclaimer: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to trade foreign exchange you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts. Any opinions, news, research, analyses, prices, or other information contained on this website is provided as general market commentary and does not constitute investment advice. Forex Capital Markets LLC. will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on such information.
Sverige
English
Español
Français
中文
Deutsch
Italiano
العربية
Ελληνικά
Reply With Quote